Arbutus Biopharma Corp (ABUS) Reports Year-End Financial Results and Progress in Clinical Trials
ABUS Announces Decrease in Annual Revenue and Net Loss for 2023
Source: yahoo.com
Stay updated with breaking news from Clinical Progress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ABUS Announces Decrease in Annual Revenue and Net Loss for 2023
Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round.
The TDR Three Key Takeaways:
Tampa General Hospital is expanding its use of Andor Health's ThinkAndor virtual hospital platform to inpatient settings.
/PRNewswire/ -- On April 20, Patsnap, the world's leading SaaS provider for intelligence, announced the launch of its latest version of the intelligence...